Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-09

Clinical Trial Update: Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation [NA]

View source ↗

Summary

The trial assessed methods to reduce fluoroscopy exposure during atrial fibrillation ablation and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Technische Universität Dresden | Conditions: Atrial Fibrillation | NA | Status: COMPLETED